VCG
Vantage Consulting Group’s Elevance Health ELV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-465
| Closed | -$252K | – | 60 |
|
|
2024
Q2 | $252K | Sell |
465
-40
| -8% | -$21.7K | 0.19% | 93 |
|
|
2024
Q1 | $262K | Sell |
505
-17
| -3% | -$8.82K | 0.17% | 94 |
|
|
2023
Q4 | $246K | Sell |
522
-67
| -11% | -$31.6K | 0.17% | 125 |
|
|
2023
Q3 | $256K | Buy |
589
+30
| +5% | +$13.1K | 0.17% | 101 |
|
|
2023
Q2 | $248K | Sell |
559
-40
| -7% | -$17.8K | 0.14% | 126 |
|
|
2023
Q1 | $275K | Buy |
599
+74
| +14% | +$34K | 0.16% | 96 |
|
|
2022
Q4 | $269K | Sell |
525
-67
| -11% | -$34.4K | 0.16% | 96 |
|
|
2022
Q3 | $269K | Buy |
592
+28
| +5% | +$12.7K | 0.16% | 96 |
|
|
2022
Q2 | $272K | Buy |
564
+4
| +0.7% | +$1.93K | 0.15% | 94 |
|
|
2022
Q1 | $275K | Sell |
560
-294
| -34% | -$144K | 0.11% | 101 |
|
|
2021
Q4 | $396K | Sell |
854
-114
| -12% | -$52.9K | 0.11% | 58 |
|
|
2021
Q3 | $361K | Buy |
968
+261
| +37% | +$97.3K | 0.08% | 61 |
|
|
2021
Q2 | $270K | Buy |
707
+143
| +25% | +$54.6K | 0.05% | 97 |
|
|
2021
Q1 | $202K | Buy |
564
+154
| +38% | +$55.2K | 0.04% | 89 |
|
|
2020
Q4 | $132K | Buy |
+410
| New | +$132K | 0.01% | 97 |
|